LYMNUTRO

Serial Number 98816226
688

Registration Progress

Application Filed
Oct 23, 2024
Under Examination
Jun 24, 2025
Approved for Publication
Apr 29, 2025
Published for Opposition
Apr 29, 2025
Registered

Attorney Assistance

Important Deadline Approaching

Notice of Allowance Mailed - SOU Required
Due: December 24, 2025 (170 days remaining)

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
98816226
Deadline
December 24, 2025
Description
Statement of Use or 1st Extension Due
Filing Date
October 23, 2024
Published for Opposition
April 29, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jun 24, 2025
Application
Pending
Classes
005

Rights Holder

X4 Pharmaceuticals, Inc.

03
Address
61 North Beacon Street, 4th Floor
Boston, MA 02134

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 688

Ownership History

X4 Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

X4 Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Glenn A. Gundersen
USPTO Deadlines
All 1 deadline(s) have been cleared by subsequent events. No active renewal deadlines at this time.

Application History

8 events
Date Code Type Description
Jun 24, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 29, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 29, 2025 PUBO A PUBLISHED FOR OPPOSITION
Apr 23, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2025 DOCK D ASSIGNED TO EXAMINER
Oct 23, 2024 NWAP I NEW APPLICATION ENTERED
Oct 23, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of WHIM syndrome; Pharmaceutical preparations for the treatment of immunodeficiencies; Pharmaceutical preparations for the treatment of neutropenia

Classification

International Classes
005